Home » Topics » Regulatory

Regulatory
RSS

Elzonris receives FDA approval for the treatment of blastic plasmacytoid dendritic cell neoplasm

Dec. 24, 2018

Toripalimab first domestically produced anti-PD-1 MAb approved in China

Dec. 20, 2018

China becomes first country to approve roxadustat

Dec. 18, 2018

Aplidin approved in Australia for the treatment of multiple myeloma

Dec. 12, 2018

FDA approves Dextenza intracanalicular insert to treat postsurgical ocular pain

Dec. 3, 2018

Precedex approved for use in pediatric patients in Japan

Nov. 30, 2018

Melinta Therapeutics granted marketing authorization for Vabomere in Europe

Nov. 28, 2018

FDA grants accelerated approval to Vitrakvi for advanced solid tumors with NTRK gene fusion

Nov. 27, 2018

European Commission approves pegfilgrastim biosimilar Pelmeg

Nov. 26, 2018

FDA approves Daurismo for newly diagnosed AML ineligible for intensive chemotherapy

Nov. 22, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...